mani
viral
genom
encod
small
integr
membran
protein
form
homooligomer
channel
membran
transport
proton
cation
molecul
across
membran
barrier
aid
variou
step
viral
entri
matur
viral
protein
collect
name
viroporin
crucial
viral
pathogen
past
five
year
structur
obtain
nuclear
magnet
reson
nmr
xray
crystallographi
electron
microscopi
em
show
viroporin
often
adopt
minimalist
architectur
achiev
function
number
small
molecul
identifi
interfer
channel
activ
therebi
inhibit
viral
infect
make
viroporin
potenti
drug
target
therapeut
intervent
known
architectur
inhibit
mechan
viroporin
differ
significantli
common
principl
share
review
articl
summar
recent
develop
structur
investig
viroporin
inhibit
antivir
compound
articl
part
special
issu
entitl
viral
membran
proteinschannel
cellular
network
past
decad
viru
research
wit
emerg
growth
special
famili
membraneembed
channel
protein
encod
genom
virus
famili
protein
collect
term
viroporin
gener
low
sequenc
homolog
ion
channel
prokaryot
eukaryot
though
certain
transmembran
tm
segment
similar
viroporin
protein
share
common
featur
small
amino
acid
hydrophob
often
dynam
due
small
size
membran
protein
must
oligomer
order
form
channel
moreov
viral
channel
appear
adopt
minimalist
function
structur
solut
drastic
differ
known
channel
structur
organ
make
structur
function
explor
viroporin
interest
reward
earli
investig
viroporin
focus
system
includ
polioviru
togaviru
influenza
viru
iav
wellknown
viroporin
implic
membran
permeabil
ion
small
molecul
later
stage
viral
infect
shown
form
cationselect
channel
insert
lipid
bilay
role
viral
life
cycl
still
poorli
character
proton
channel
far
receiv
biggest
spotlight
target
success
antiflu
drug
amantadin
rimantadin
phdepend
proton
conduct
channel
knowledg
proton
channel
long
time
limit
sinc
discoveri
protein
viroporin
famili
grown
substanti
tabl
human
immunodefici
viru
type
vpu
hepat
c
viru
hcv
shown
conduct
cation
influenza
b
viral
genom
encod
protein
function
homolog
sensit
adamantan
famili
drug
viral
k
channel
paramecium
bursaria
chlorella
viru
contain
select
filter
prokaryot
eukaryot
k
channel
propos
adopt
similar
structur
kcsa
apart
ion
channel
polioviru
develop
channel
permeat
singlestrand
rna
across
membran
expand
list
substrat
viroporin
transport
exact
function
viroporin
mani
virus
yet
known
though
role
implic
entri
viral
assembl
viral
releas
particular
role
proton
channel
influenza
replic
less
accept
one
role
channel
equilibr
ph
across
viral
membran
cell
entri
acidifi
virion
interior
endocytosi
facilit
rna
releas
anoth
role
equilibr
ph
across
transgolgi
membran
infect
cell
viral
matur
preserv
prefus
form
hemagglutinin
deacidif
golgi
lumen
role
cationselect
viroporin
howev
clear
case
hcv
channel
activ
report
facilit
viru
releas
fact
one
gener
role
propos
viroporin
depolar
either
endoplasm
reticulum
er
plasma
membran
facilit
membran
curvatur
bud
anoth
gener
role
viroporin
simpli
caus
cation
leakag
cellular
stress
would
induc
program
cell
death
addit
ion
permeat
sever
viroporin
known
particip
viral
assembl
interact
protein
exampl
iav
ibv
protein
signific
cytoplasm
domain
involv
recruit
matrix
protein
viru
assembl
hcv
protein
also
report
interact
nonstructur
protein
interact
appear
crucial
product
infecti
hcv
particl
precis
function
ion
conduct
activ
mani
viroporin
remain
discov
advanc
structur
character
influenza
hcv
protein
provid
compel
evid
viroporin
simpl
porin
adopt
interest
architectur
regul
transport
activ
ph
depend
proton
transport
select
cation
conduct
furthermor
structur
character
interact
viroporin
small
molecul
inhibitor
reveal
conceptu
differ
mechan
channel
protein
inhibit
thu
allud
new
opportun
use
viroporin
antivir
target
current
review
describ
recent
character
viroporin
architectur
intrigu
minimalist
mode
assembl
new
structur
inform
explain
observ
function
properti
viroporin
review
also
describ
exampl
viroporin
inhibit
known
antivir
drug
explain
mechan
drug
inhibit
drug
resist
structur
studi
viroporin
easi
small
membran
protein
typic
dynam
sensit
hydrophob
surround
last
five
year
multipl
biophys
techniqu
includ
solut
nmr
xray
crystallographi
solidst
nmr
em
use
gradual
fill
knowledg
gap
exampl
structur
inform
channel
domain
crystal
solut
state
lipid
bilay
differ
ph
bound
differ
small
molecul
complementari
structur
data
allow
elucid
function
mechan
differ
view
angl
addit
influenza
proton
channel
structur
fulllength
channel
hcv
recent
determin
case
structur
determin
reveal
unexpect
structur
featur
import
understand
function
mechan
protein
iav
protein
ibv
singlepass
membran
protein
respect
form
homotetram
membran
two
protein
share
almost
sequenc
homolog
except
hxxxw
sequenc
motif
tm
domain
essenti
channel
activ
domain
arrang
also
differ
tm
region
encompass
residu
residu
henc
unstructur
ntermin
segment
preced
tm
domain
much
longer
sought
possibl
target
vaccin
develop
addit
membraneembed
channel
domain
rel
larg
ctermin
cytoplasm
region
region
suggest
play
role
viral
assembl
recruit
matrix
protein
cell
surfac
viru
bud
andor
contribut
coat
matrix
protein
viral
envelop
first
detail
structur
channel
determin
concurr
solut
nmr
spectroscopi
xray
crystallographi
subsequ
xray
solut
nmr
studi
determin
structur
channel
domain
differ
condit
differ
drug
resist
mutat
moreov
structur
character
solidst
nmr
spectroscopi
also
gener
work
structur
model
channel
lipid
bilay
environ
structur
solv
differ
condit
show
substanti
differ
conform
fig
suggest
assembl
channel
quit
dynam
sensit
reconstitut
environ
structur
plastic
could
one
major
factor
caus
technic
difficulti
structur
determin
despit
conform
variabl
experiment
structur
converg
common
mode
channel
assembl
lefthand
fourhelix
bundl
form
channel
pore
tetramer
four
tm
helic
stabil
intermolecular
contact
ctermin
amphipath
helic
flank
tm
domain
mode
tm
helix
assembl
place
h
w
hxxxw
sequenc
motif
insid
channel
four
imidazol
ring
ph
trigger
devic
essenti
transport
proton
pack
close
insid
pore
moreov
pack
indol
creat
channel
gate
occlud
ctermin
end
pore
detail
structur
channel
domain
solv
use
solut
nmr
method
channel
also
assembl
lefthand
helic
pack
unlik
pack
show
strong
coiledcoil
characterist
regular
heptad
repeat
fig
coiledcoil
tetram
posit
heptad
repeat
occupi
mostli
serin
form
hydrophil
pore
posit
g
e
occupi
leucin
phenylalanin
respect
allow
hydrophob
pack
peripher
leucin
phenylalanin
arrang
coiledcoil
assembl
membran
opposit
watersolubl
coiledcoil
tetram
posit
typic
hydrophob
residu
posit
g
e
polar
residu
invers
coiledcoil
assembl
membran
place
histidin
tryptophan
hxxxw
motif
insid
pore
cytoplasm
domain
also
lefthand
coiledcoil
tetram
watersolubl
strong
bipolar
distribut
surfac
charg
residu
domain
specif
interact
matrix
protein
structur
arrang
histidin
tryptophan
insid
pore
impli
role
imidazol
proton
select
devic
indol
channel
gate
fig
inde
function
assay
nmr
measur
suggest
proton
conduct
across
channel
involv
cycl
histidin
proton
deproton
histidin
serv
proton
shuttl
devic
concern
histidin
proton
multipl
histidin
proton
charg
repuls
would
strong
enough
destabil
tetram
issu
howev
resolv
fact
histidin
proton
time
proton
one
histidin
would
increas
barrier
proton
anoth
histidin
inde
multipl
pka
valu
observ
proton
conduct
assay
therefor
current
understand
proton
conduct
mechan
histrp
structur
element
constitut
minim
requir
unit
phdepend
proton
transport
fig
propos
ref
close
state
two
pair
histidin
tetram
share
one
proton
explain
high
pk
lower
ph
result
proton
third
histidin
ntermin
side
turn
result
disrupt
two
histidin
dimer
proton
conduct
remain
question
address
futur
third
proton
result
conform
chang
tryptophan
would
allow
relay
proton
ctermin
side
tryptophan
gate
final
signific
structur
differ
channel
show
strong
abil
influenza
viru
evolv
differ
solut
achiev
goal
viroporin
protein
encod
hcv
genom
protein
oligomer
membran
form
cationselect
channel
higher
select
ca
k
na
channel
activ
import
assembl
releas
infecti
virus
although
molecular
mechan
function
remain
elus
case
structur
character
confront
challeng
prepar
concentr
homogen
sampl
oligom
earlier
nmr
studi
found
monom
three
helic
segment
two
ntermin
half
sequenc
one
near
cterminu
nmr
studi
perform
condit
believ
support
monomer
state
although
monomer
state
unlik
conduct
ion
could
involv
interact
protein
viru
assembl
first
structur
investig
assembl
oligom
conduct
use
singleparticl
em
obtain
resolut
electron
densiti
map
protein
complex
map
show
hcv
genotyp
strain
form
kda
hexam
adopt
flowerlik
shape
resembl
known
ion
channel
structur
databas
structur
investig
valid
stabl
hexamer
complex
structur
detail
requir
understand
ion
conduct
drug
inhibit
remain
unknown
recent
effect
solut
nmr
system
hexam
establish
use
genotyp
strain
one
less
hydrophob
sequenc
among
variant
use
nmr
system
detail
structur
hexam
eventu
determin
nmr
structur
channel
show
hcv
develop
solut
conduct
cation
substanti
differ
known
k
ca
channel
channel
funnellik
architectur
six
minimalist
chain
contain
three
helic
segment
helic
monom
form
narrow
wide
region
funnelshap
caviti
respect
helic
wrap
channel
peripher
interact
monom
fig
intramonom
contact
three
helic
segment
context
hexam
high
order
oligomer
maxim
interact
monom
allow
small
hydrophob
peptid
form
kda
channel
complex
although
minimalist
architectur
compar
ca
mg
channel
hexam
appear
possess
essenti
featur
ion
channel
pore
element
support
select
ion
dehydr
gate
constrict
prevent
nonspecif
permeat
open
respons
regul
factor
ph
voltag
ligand
ion
select
channel
interior
number
strongli
conserv
residu
like
candid
serv
function
obviou
one
form
ring
carboxamid
near
narrow
end
channel
fig
residu
asparagin
strain
except
substitut
histidin
genotyp
virus
format
ring
carboxyl
carboxamid
recur
theme
prokaryot
eukaryot
channel
select
dival
cation
exampl
central
cora
mg
channel
pentamer
ring
asparagin
moreov
recent
structur
calcium
releaseactiv
calcium
crac
channel
orai
show
hexamer
ring
aspart
acid
channel
strong
select
dival
cation
although
also
conduct
monoval
cation
na
k
proxim
ring
hydrophob
ring
form
defin
narrowest
point
channel
residu
isoleucin
valin
throughout
hcv
genotyp
subtyp
therefor
narrow
hydrophob
ring
posit
like
serv
hydrophob
constrict
prevent
water
freeli
pass
mechan
cation
conduct
envisag
structur
role
ring
provid
ion
select
recruit
dehydr
cation
near
funnel
exit
unhydr
cation
pass
hydrophob
ring
regard
featur
broad
select
filter
addit
appear
cation
select
ring
near
narrow
ntermin
exit
channel
wider
ctermin
entranc
channel
decor
conserv
ring
arginin
lysin
placement
posit
charg
ring
entranc
incomprehens
us
initi
may
repel
cation
earlier
studi
report
design
tm
barrel
intern
argininehistidin
dyad
form
effici
cation
select
channel
immobil
arginin
recruit
mobil
anion
turn
facilit
cation
diffus
pore
interest
note
highli
basic
region
contain
pore
also
found
crac
orai
structur
one
possibl
role
basic
residu
cation
select
channel
bind
obstruct
anion
allow
cation
diffus
pore
mechan
would
consist
observ
replac
neg
charg
aspart
acid
larg
abrog
conduct
final
unresolv
issu
nmr
structur
size
ring
inner
significantli
larger
eg
crac
cora
crystal
structur
size
carboxamid
ring
clearli
provid
tight
coordin
ca
rais
number
question
need
address
futur
nmr
structur
solv
absenc
ca
inhibitor
repres
open
close
state
channel
two
state
exist
ca
select
strong
highli
regul
ca
channel
crac
develop
gener
unspecif
cation
channel
purpos
dissip
membran
potenti
address
question
would
requir
structur
investig
differ
condit
extens
character
channel
conduct
properti
singlechannel
measur
structur
perspect
funnellik
architectur
form
multipl
helic
segment
connect
hing
short
loop
believ
flexibl
afford
dynam
open
close
tip
channel
addit
viroporin
structur
structur
character
conduct
sever
viroporin
combin
use
solidst
nmr
pisema
experi
solut
nmr
first
identifi
membraneassoci
region
vpu
protein
includ
tm
helix
juxtamembran
amphipath
helix
parallel
membran
research
group
obtain
detail
structur
tm
helix
tilt
angl
rel
lipid
bilay
combin
comput
model
provid
homopentamer
model
vpu
channel
somewhat
differ
model
pentamer
vpu
recent
develop
use
intermonom
distanc
restraint
magic
angl
spin
ma
nmr
experi
suggest
vpu
like
also
adopt
substanti
structur
variabl
addit
vpu
oligomer
state
analys
perform
kcv
protein
e
protein
sarscov
studi
suggest
kcv
form
homotetram
e
protein
form
stabl
pentam
believ
viroporin
may
adopt
interest
architectur
well
transport
ion
one
motiv
investig
viroporin
anticip
structur
differ
human
channel
thu
potenti
antivir
drug
target
success
exampl
antivir
drug
target
viroporin
amantadin
symadin
rimantadin
flumadin
inhibit
proton
conduct
channel
first
licens
drug
treat
influenza
infect
rimantadin
also
shown
inhibit
hcv
channel
sinc
first
success
drug
target
viroporin
research
viral
membran
protein
identifi
sever
viroporin
inhibitor
vari
efficaci
includ
hexamethylen
amilorid
inhibit
vpu
hcv
e
sarscov
longalkylchain
iminosugar
deriv
inhibit
hcv
well
new
compound
inhibit
vpu
hcv
mechan
amantadinerimantadin
inhibit
channel
elus
recent
previou
confus
came
mainli
multipl
bind
site
observ
experiment
crystallograph
studi
tm
domain
residu
presenc
amantadin
drug
densiti
found
insid
channel
near
residu
structur
resolut
difficult
confirm
posit
amantadin
bind
time
howev
solut
nmr
studi
longer
version
residu
show
rimantadin
bind
extern
lipidfac
pocket
around
residu
adjac
tm
helic
mechanist
implic
two
bind
site
obvious
differ
one
drug
directli
block
channel
passag
alloster
mechan
drug
bind
extern
site
favor
close
state
channel
subsequ
solidst
nmr
measur
tm
domain
lipid
bilay
show
rimantadin
bind
site
higher
affin
pore
site
function
studi
use
chimera
protein
provid
strongest
evid
pore
bind
site
primari
site
drug
inhibit
studi
author
use
chimera
variant
influenza
b
virus
contain
porebind
site
show
chimera
channel
still
sensit
amantadin
rimantadin
inhibit
indic
porebind
site
primari
site
drug
inhibit
later
structur
tm
domain
chimera
complex
rimantadin
determin
nmr
provid
precis
view
drug
bind
insid
channel
pore
structur
show
eight
methyl
group
tetram
two
subunit
c
h
c
h
togeth
form
deep
intern
pocket
complet
wrap
adamantan
cage
drug
fig
nitrogen
rimantadin
amino
group
averag
backbon
carbonyl
oxygen
one
four
subunit
probabl
form
hydrogen
bond
termin
methyl
group
rimantadin
middl
pore
face
open
space
channel
around
posit
structur
also
show
rimantadin
bind
slightli
tilt
vertic
axi
symmetri
axi
channel
tilt
angl
consist
amantadin
tilt
channel
observ
solidst
nmr
spectroscopi
although
amantadin
rimantadin
wide
use
antiinfluenza
drug
decad
drug
resist
variant
widespread
resist
n
report
mutat
confer
resist
includ
among
account
vast
major
resist
strain
obviou
rimantadinebound
nmr
structur
chang
size
andor
hydrophob
adamantan
bind
pocket
mutat
like
caus
steric
collis
amino
methyl
group
drug
moreov
introduc
four
neg
charg
insid
small
pore
could
alter
channel
conform
mutat
less
straightforward
explain
face
helixhelix
interfac
appear
involv
direct
interact
drug
previou
nmr
analysi
mutant
suggest
replac
much
bulkier
asparagin
effect
destabil
helic
pack
believ
mutat
abrog
drug
bind
alloster
disrupt
loosen
intern
bind
pocket
modifi
adamantan
compound
overcom
mutat
clearli
easi
recent
studi
report
conjug
ch
heteroaryl
group
amin
amantadin
lead
signific
inhibit
mutant
addit
block
channel
adamantan
deriv
amantadin
rimantadin
also
report
pose
inhibitori
effect
channel
conduct
therapeut
relev
find
howev
controversi
clinic
trial
investig
amino
acid
variat
respons
antivir
therapi
amantadin
treat
hcv
genotyp
infect
patient
amantadin
clinic
studi
signific
correl
overal
amino
acid
variat
respons
treatment
found
although
mutat
observ
often
drug
resist
patient
anoth
vitro
studi
use
singlechannel
record
techniqu
show
activ
genotyp
sensit
amantadin
discrep
around
amantadin
inhibit
could
explain
sequenc
variat
among
differ
genotyp
inde
systemat
investig
use
multipl
function
readout
includ
viral
entri
releas
demonstr
substanti
genotypedepend
subtypedepend
sensit
sever
inhibitor
includ
amantadin
rimantadin
sequenc
differ
suffici
local
enabl
elucid
drug
bind
locat
recent
structur
character
hcv
provid
detail
view
bind
site
amantadin
rimantadin
nmr
measur
channeldrug
complex
reveal
amantadin
rimantadin
bind
six
equival
hydrophob
pocket
due
sixfold
symmetri
channel
poreform
peripher
helic
fig
site
monom
monom
monom
togeth
form
deep
hydrophob
pocket
wrap
around
adamantan
cage
drug
amino
group
amantadin
rimantadin
face
larg
hydrophil
channel
lumen
import
properti
drug
bind
site
consist
element
differ
helic
segment
differ
monom
ration
permeat
cation
channel
may
depend
open
narrow
end
funnel
turn
depend
reorient
helic
segment
bind
adamantan
deriv
pocket
may
inhibit
channel
activ
alloster
caus
channel
close
compar
amantadin
rimantadin
bind
mode
hcv
influenza
show
two
fundament
differ
mechan
drug
inhibit
case
one
drug
bind
one
channel
drug
bind
inhibit
proton
transport
directli
block
channel
passag
also
prevent
channel
open
case
amantadin
rimantadin
clearli
small
block
channel
instead
bind
six
equival
site
outsid
channel
caviti
afford
six
drug
per
channel
rimantadin
bind
site
relev
inhibit
crude
suggest
previou
function
mutagenesi
drug
bind
site
inhibit
cation
conduct
alloster
mechan
possibl
stabil
close
state
channel
although
mechan
drug
inhibit
may
complet
differ
structur
base
govern
drugbind
affin
actual
similar
involv
hydrophob
size
pocket
posit
drug
amino
group
case
tetram
drug
adamantan
cage
fit
snuggli
hydrophob
pocket
form
eight
methyl
group
two
subunit
drug
amino
group
form
polar
contact
backbon
oxygen
point
polar
region
channel
caviti
fig
channel
adamantan
cage
contact
ten
methyl
group
aromat
group
protein
hydrophob
group
form
deep
hydrophob
pocket
also
match
close
size
adamantan
cage
fig
amino
group
amantadin
rimantadin
point
channel
lumen
posit
form
polar
contact
electroneg
group
backbon
carbonyl
residu
similar
amantadin
rimantadin
bind
allud
similar
mechan
drug
resist
known
drug
resist
mutat
confer
resist
decreas
hydrophob
adamantan
bind
pocket
conceptu
consist
observ
mutat
confer
drug
resist
case
function
assay
show
fig
amantadin
rimantadin
bind
site
channel
precis
nmr
structur
rimantadin
bound
intern
pocket
chimer
channel
determin
dhpc
micel
ph
left
panel
detail
illustr
methyl
group
green
interact
adamantan
cage
right
panel
surfac
represent
show
hydrophob
pocket
fit
drug
snuggli
one
four
subunit
omit
drug
visibl
b
amantadin
rimantadin
bind
site
channel
determin
nmr
dpc
micel
ph
left
panel
drug
bind
six
equival
hydrophob
pocket
channel
right
panel
close
view
amantadin
dock
bind
pocket
determin
use
nmr
noe
restraint
singl
mutat
well
doubl
mutat
also
significantli
reduc
rimantadin
inhibit
unpublish
data
mutat
decreas
hydrophob
adamantan
bind
pocket
thu
variat
hydrophob
adamantan
bind
pocket
among
variant
explain
larg
differ
drug
efficaci
observ
differ
hcv
genotyp
virus
develop
membraneembed
viroporin
transport
ion
solut
viral
life
cycl
name
porin
seem
impli
leaki
pore
similar
porin
bacteria
recent
structur
data
show
viroporin
sophist
leaki
pore
although
viroporin
gener
adopt
minimalist
architectur
essenti
structur
element
compat
select
transport
proton
andor
cation
viral
channel
may
function
robust
specif
regul
counterpart
prokaryot
eukaryot
virus
often
need
intric
regul
channel
activ
infect
cycl
nonetheless
uniqu
structur
viroporin
provid
uniqu
opportun
develop
novel
antivir
therapeut
believ
multipl
biophys
biochem
tool
establish
structur
studi
membran
protein
new
viroporin
architectur
discov
faster
pace
despit
progress
structur
determin
major
challeng
lie
ahead
viroporin
research
precis
function
role
mani
viroporin
still
unclear
moreov
due
lack
robust
singlechannel
record
setup
suitabl
viroporin
ion
conduct
properti
viroporin
fulli
character
therefor
better
definit
function
aspect
viroporin
certainli
draw
greater
enthusiasm
develop
therapeut
target
interest
famili
membran
channel
fig
comparison
adamantan
bind
site
influenza
hcv
channel
intern
pocket
wrap
around
adamantan
cage
rimantadin
determin
earlier
chimer
channel
chimer
channel
wellbehav
model
system
studi
influenza
channel
ntermin
half
influenza
protein
sensit
amantadin
rimantadin
inhibit
ctermin
half
influenza
b
protein
insensit
amantadin
rimantadin
one
subunit
tetramer
complex
remov
unveil
channel
interior
b
peripher
pocket
helic
amantadin
bind
repres
pocket
among
six
equival
pocket
hexam
